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Body Mass Index and Waist Circumference According to Glucose 
Tolerance Status in Korea: The 2005 Korean Health and Nutrition 
Examination Survey
The purpose of this study was to investigate the stage of glucose intolerance in which 
persons showed a maximum obesity in Korea. A total of 4,479 participants, who were 
involved in the 2005 Korean National Health and Nutrition Examination Survey, was 
examined. The participants were divided into 5 groups by fasting plasma glucose (FPG); 
normal fasting glucose (NFG)1, FPG  < 90 mg/dL; NFG2, FPG 90-99 mg/dL; impaired 
fasting glucose (IFG)1, FPG 100-109 mg/dL; IFG2, FPG 110-125 mg/dL; and diabetes 
mellitus, FPG  ≥ 126 mg/dL or with anti-diabetes drugs. In those with FPG  < 110 mg/dL, 
body mass index (BMI) and waist circumference (WC) were increased with increase of FPG 
(BMI in men; NFG1, 23.3 ± 0.1; NFG2, 24.4 ± 0.1; IFG1, 25.0 ± 0.2 kg/m
2, in women; 
NFG1, 23.0 ± 0.1; NFG2, 24.0 ± 0.1; IFG1, 24.8 ± 0.2 kg/m
2, WC in men; NFG1, 
82.1 ± 0.3; NFG2, 85.3 ± 0.3; IFG1, 86.7 ± 0.5 cm, in women; NFG1, 77.1 ± 0.2; 
NFG2, 79.4 ± 0.3; IFG1, 81.8 ± 0.6 cm). In IFG2 and diabetes range, there was no more 
increase of BMI and WC with increase of FPG in each sex. The data suggest that degree of 
obesity increases with an increase of FPG in range of FPG  < 100 mg/dL, peaked in FPG of 
100-109 mg/dL, and then plateaus in higher FPG range in general Korean population. 
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INTRODUCTION
Obesity and weight gain are associated with an increased risk of 
developing diabetes (1-3). Weight control is important in the 
management of diabetes and prevention of developing diabe-
tes in pre-diabetic individuals (4, 5). Visceral adiposity and waist 
circumference are, also, strong risk factors for type 2 diabetes (6, 
7) and an increased waist circumference was associated with 
diabetes incidence in impaired fasting glucose (IFG) range (6).
  Despite lower body mass index (BMI), some Asian countries 
have similar or even higher prevalence of diabetes than West-
ern countries (8). Several studies about the association obesity 
with diabetes prevalence in Korean population showed similar 
results (9, 10). These data suggested that the risk of type 2 dia-
betes starts at a lower BMI for Asians than for Europeans (11). 
In previous study including 370 oral glucose tolerance data, we 
found that the worsening from normal glucose tolerance (NGT) 
to impaired glucose tolerance (IGT) was more closely related to 
impaired early-phase insulin secretion than insulin resistance 
in Korean population (12). Fukushima et al., also, found that at 
all stages of glucose intolerance, Japanese individuals had re-
duced early and late phases of insulin responses (13). In Japa-
nese men with NGT, even a small increase in BMI produced a 
decrease in beta cell function disproportionate to that in insulin 
resistance (14). 
  Many Western studies showed that before development of 
diabetes, body weight increases progressively, reaching a maxi-
mum at the time of diagnosis, and then it tends to decrease after 
diagnosis (6, 15-21). Although few studies reported about the 
association between weight changes and diabetes in Korea (22-
24), all of their participants were persons who visited out-pa-
tients clinic in university hospitals. With limitations of selection 
bias, the result could not be generalized in Korean population 
across the nation. 
  We hypothesized that the stage of reaching a maximal obesi-
ty in the course of deterioration from normal glucose to diabe-
tes could be different between Western and Korean population 
if Koreans have relatively smaller capacity of insulin secretion to 
compensate increased insulin resistance according to obesity. 
The purpose of this study is to investigate the stage of glucose in-
tolerance participants showed a maximum obesity. So, we tried 
to examine the association of body mass index (BMI) and waist 
circumference (WC) with glucose tolerance status in a nation-
wide representative population using the 2005 Korean National 
Health and Nutrition Examination Survey (KNHANES) data. Kang HM, et al.  •  Body Mass Index, Waist Circumference, and Glucose Tolerance Status
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MATERIALS AND METHODS
Study population
This study was based on the data obtained from the third Korea 
National Health and Nutrition Examination Survey (KNHANES 
2005) among non-institutionalized civilians in the Republic of 
Korea, which was conducted by the Korean Ministry of Health 
and Welfare in 2005. This survey was a nationwide representa-
tive study using a stratified, multistage probability sampling de-
sign for the selection of household units. The survey consisted 
of health interview, health behavior, health examination, nutri-
tion components. A total of 34,145 individuals from these sam-
pling frames were included in the health interview survey. Among 
them, 5,531 persons were identified as participants with labora-
tory test and nutritional survey data. We included only partici-
pants older than 25 yr for excluding the possibilities of type 1 DM. 
Participants with history of cancer, cerebrovascular disease, end 
stage renal disease, liver cirrhosis, and thyroid disease were ex-
cluded because of its effect on weight. Finally, 4,479 persons 
aged 26-99 yr were identified as participants. 
  The participants were divided into five groups by fasting plas-
ma glucose (FPG); normal fasting glucose (NFG)1, FPG < 90 mg/ 
dL; NFG2, FPG 90-99; impaired fasting glucose (IFG)1, FPG 100-
109; IFG2, FPG 110-125; DM: FPG  ≥ 126 or those with anti-dia-
betes drugs. Clinical practice guidelines for type 2 diabetes in 
Korea 2011 recommended screening methods differently accord-
ing to stage of IFG (stage 1, FPG 100-109 mg/dL, stage2: FPG 
110-125) (25). So we divided our IFG participants into two groups 
according to above mentioned criteria. In case of NFG, we grouped 
our NFG participants by 10 mg/dL from FPG of 100 mg/dL arbi-
trarily.    
 
Health examination survey and laboratory test 
Trained interviewers visited each participant’s dwelling and ad-
ministered a standardized questionnaire on smoking and alco-
hol consumption. Height and weight were obtained using stan-
dardized techniques and equipment. Height was measured to 
the nearest 0.1 cm using a portable standiometer (Seriter, Bis-
marck, ND). Weight was measured to the nearest 0.1 kg using a 
calibrated balance-beam scale (Giant-150N; Hana, Seoul, Korea). 
BMI was calculated by dividing weight by height squared (kg/
m
2). WC was measured on standing participants with a soft tape 
midway between the lowest rib and the iliac crest. Systolic blood 
pressure (SBP) and diastolic blood pressure (DBP) were mea-
sured by standard methods using a sphygmomanometer with 
the patient in a sitting position. Three measurements were made 
on all subjects at 5-min intervals; the average of the second and 
third measurements was used in the analysis. Blood samples 
were collected in the morning after fasting for at least 8 hr. FPG, 
aspartate aminotransferase (AST), alanine aminotransferase 
(ALT), total cholesterol (TC), triglycerides (TG), and high-den-
sity lipoprotein cholesterol (HDL-C) levels were measured in a 
central and certified laboratory using an Advia 1650 (Siemens, 
Washington, DC, USA). Low-density lipoprotein cholesterol 
(LDL-C) was estimated indirectly using the Friedwald formula: 
LDL-C = TC - (HDL-C + [TG/5]), for subjects with TG levels 
< 400 mg/dL. White blood cell (WBC) was measured using an 
Advia 120 (Siemens).
Statistical analysis 
Data are presented as mean ± SEM or %. All statistical techniques 
were performed using the Statistical Package for the Social Sci-
ences for Personal Computer (SPSS, Chicago, IL, USA). ANCOVA 
was used to estimate BMI and WC according to FPG in each 
Table 1. Age and age-adjusted characteristics according to glucose tolerance status in 1,952 Korean adult males
Parameters
FPG (mg/dL)
Diabetes  P for trend
-89 90-99 100-109 110-125
Number 705 675 256 133 183
Age (yr) 44.0 ± 0.5 47.5 ± 0.5 50.4 ± 0.8 53.9 ± 1.1 56.5 ± 0.9 < 0.001
FPG (mg/dL) 83.6 ± 0.7 94.0 ± 0.7 103.9 ± 1.1 115.6 ± 1.5 154.9 ± 1.3 < 0.001
Current smoking (%) 47.1 ± 1.9 40.9 ± 1.9 35.9 ± 3.1 39.6 ± 4.3 47.7 ± 3.7 0.008
Alcohol intake (g/day) 12.8 ± 1.8 19.3 ± 1.8 18.0 ± 2.8 15.3 ± 4.0 29.5 ± 3.5 < 0.001
SBP (mmHg) 120.8 ± 0.6 122.9 ± 0.6 126.4 ± 0.9 124.4 ± 1.3 126.1 ± 1.1 < 0.001
DBP (mmHg) 79.3 ± 0.4 81.3 ± 0.4 83.8 ± 0.6 83.3 ± 0.9 82.0 ± 0.8 < 0.001
WBC (/µL) 6,625 ± 69 6,856 ± 69 6,761 ± 110 9,814 ± 160 7,420 ± 140 < 0.001
ALT (U/L) 25.2 ± 0.9 27.4 ± 0.9 37.3 ± 1.5 34.3 ± 2.1 32.3 ± 1.8 < 0.001
AST (U/L) 26.5 ± 0.7 26.2 ± 0.7 31.0 ± 1.1 31.8 ± 1.5 31.6 ± 1.3 < 0.001
LDL-C (mg/dL) 110.6 ± 1.2 116.7 ± 1.2 115.4 ± 2.0 118.9 ± 2.8 112.9 ± 2.5 0.001
HDL-C (mg/dL) 42.9 ± 0.4 42.1 ± 0.4 41.8 ± 0.6 42.7 ± 0.9 38.7 ± 0.8 < 0.001
TG (mg/dL) 139.3 ± 6.1 152.6 ± 6.2 186.7 ± 10.1 200.4 ± 14.0 277.0 ± 12.1 < 0.001
Waist circumference (cm) 82.1 ± 0.3 85.3 ± 0.3 86.7 ± 0.5 88.2 ± 0.7 87.9 ± 0.6 < 0.001
BMI (kg/m
2) 23.3 ± 0.1 24.4 ± 0.1 25.0 ± 0.2 25.2 ± 0.3 24.9 ± 0.2 < 0.001
FPG, fasting plasma glucose; SBP, systolic blood pressure; DBP, diastolic blood pressure; WBC, white blood cell; ALT, alanine transaminase; AST, aspartate transaminase; LDL-C, 
low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; TG, triglyceride; BMI, body mass index.Kang HM, et al.  •  Body Mass Index, Waist Circumference, and Glucose Tolerance Status
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sex. Statistical significance was defined as P < 0.05. 
Ethics statement
This study was approved by the institutional review board of the 
Ilsan Paik Hospital (IB-3-1107-027). After approval of study pro-
posal, KNHANES dataset were available on the request of inves-
tigator. Because the dataset did not include any personal infor-
mation and participant’s consent was already taken in the pro-
cess of KNHANES, our study was exempted from participant’s 
consent by the board.
RESULTS
A total of 4,479 participants (1,952 men and 2,527 women) were 
analyzed. The mean BMI was 23.9 ± 3.2 kg/m
2 (24.1 ± 3.1 kg/m
2 
in men, 23.6 ± 3.3 kg/m
2 in women). 
  Table 1 summarizes the data of age and age-adjusted charac-
teristics according to glucose tolerance status in Korean adult 
men. Before development of diabetes, there was a progressive 
rise in BMI and WC according to an increase of FPG (BMI; NFG1, 
23.3 ± 0.1; NFG2, 24.4 ± 0.1; IFG1, 25.0 ± 0.2; IFG2, 25.2 ± 0.3; 
DM, 24.9 ± 0.2 kg/m
2 [P for trend < 0.001], WC; NFG1, 82.1 ±  
0.3; NFG2, 85.3 ± 0.3; IFG1, 86.7 ± 0.5; IFG2, 88.2 ± 0.7; DM, 
87.9 ± 0.6 cm [P for trend < 0.001]).
  Table 2 summarizes the data of age and age-adjusted charac-
teristics according to glucose tolerance status in Korean adult 
women. Before development of diabetes, there was a progres-
sive rise in BMI according to an increase of FPG (BMI; NFG1, 
23.0 ± 0.1; NFG2, 24.0 ± 0.1; IFG1, 24.8 ± 0.2; IFG2, 25.1 ± 0.4; 
DM, 24.9 ± 0.3 kg/m
2 [P for trend < 0.001]). WC was increased 
Table 2. Age and age-adjusted characteristics according to glucose tolerance status in 2,527 Korean adult females 
Parameters
FPG (mg/dL)
Diabetes  P for trend
-89 90-99 100-109 110-125
Number 1,285 777 229 82 154
Age (yr) 44.0 ± 0.4 49.7 ± 0.5 54.4 ± 0.9 55.0 ± 1.5 61.2 ± 1.0 < 0.001
FPG (mg/dL) 83.6 ± 0.3 93.6 ± 0.4 103.8 ± 0.8 116.0 ± 1.3 147.4 ± 1.0 < 0.001
Current smoking (%) 3.3 ± 0.5 3.8 ± 0.7 2.4 ± 1.2 6.7 ± 2.0 4.6 ± 1.5 NS
Alcohol intake (g/day) 2.7 ± 0.3 2.1 ± 0.4 2.8 ± 0.8 2.7 ± 1.3 3.2 ± 1.0 NS
SBP (mmHg) 115.2 ± 0.4 117.4 ± 0.5 118.8 ± 1.0 125.0 ± 1.6 122.6 ± 1.2 < 0.001
DBP (mmHg) 74.1 ± 0.3 75.6 ± 0.3 76.9 ± 0.6 78.8 ± 1.1 76.1 ± 0.8 < 0.001
WBC (/µL) 5,646 ± 47 5,851 ± 59 6.006 ± 110 6,380 ± 182 6,774 ± 136 < 0.001
ALT (U/L) 16.8 ± 0.3 18.0 ± 0.4 19.9 ± 0.7 19.5 ± 1.2 23.2 ± 0.9 < 0.001
AST (U/L) 22.0 ± 0.2 22.2 ± 0.3 22.1 ± 0.6 22.0 ± 0.9 22.6 ± 0.7 NS
LDL-C (mg/dL) 114.8 ± 0.8 116.4 ± 1.0 122.9 ± 1.9 122.1 ± 3.2 115.8 ± 2.5 0.001
HDL-C (mg/dL) 48.6 ± 0.3 45.8 ± 0.4 45.1 ± 0.7 45.3 ± 1.2 43.1 ± 0.9 < 0.001
TG (mg/dL) 107.4 ± 2.2 112.5 ± 2.8 129.4 ± 5.2 140.1 ± 8.7 176.9 ± 6.5 < 0.001
Waist circumference (cm) 77.1 ± 0.2 79.4 ± 0.3 81.8 ± 0.6 83.3 ± 1.0 83.7 ± 0.7 < 0.001
BMI (kg/m
2) 23.0 ± 0.1 24.0 ± 0.1 24.8 ± 0.2 25.1 ± 0.4 24.9 ± 0.3 < 0.001
FPG, fasting plasma glucose; SBP, systolic blood pressure; DBP, diastolic blood pressure; WBC, white blood cell; ALT, alanine transaminase; AST, aspartate transaminase; LDL-C, 
low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; TG, triglyceride; BMI, body mass index.
Fig. 1. Age-adjusted waist circumference according to fasting plasma glucose (FPG). Diabetes was defined as current medication of anti-diabetes or FPG ≥ 126 mg/dL. Data, 
mean ± SEM. 
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according to an increase of FPG (WC; NFG1, 77.1 ± 0.2; NFG2, 
79.4 ± 0.3; IFG1, 81.8 ± 0.6; IFG2, 83.3 ± 1.0; DM, 83.7 ± 0.7 cm 
[P for trend < 0.001]).
  Fig. 1 depicts results of age-adjusted WC according to FPG 
and diabetes. In men, age-adjusted WC of NFG2 was significant-
ly higher compared to that of NFG1 (P < 0.001) and age-adjusted 
WC of IFG1 was significantly higher compared to that of NFG2 
(P = 0.017). Similar results were observed in women (WC of 
NFG2 vs NFG1, P < 0.001; IFG1 vs NFG2, P < 0.001). In each 
sex, there was no further increase of WC with increase of FPG 
in IFG1, IFG2, and DM.   
  Fig. 2 depicts age-adjusted BMI according to FPG and diabe-
tes. In men, age-adjusted BMI of NFG2 was significantly higher 
compared to that of NFG1 (P < 0.001) and age-adjusted BMI   
of IFG1 was significantly higher compared to that of NFG2 (P =  
0.005). The similar results were observed in women (BMI of 
NFG2 vs NFG1, P < 0.001; IFG1 vs NFG2, P = 0.001). In each 
sex, there was no further increase of BMI with increase of FPG 
in IFG1, IFG2, and DM.
DISCUSSION
As far as we know, this is the first study about in which stage of 
glucose intolerance persons showed a maximum obesity in  
Korean general population. The data suggested that degree of 
obesity increased with an increase of FPG in range of FPG < 100 
mg/dL, peaked in FPG of 100-109 mg/dL, and then plateaued 
in higher FPG range in general Korean population. Contrary to 
our results, many Western studies showed that before develop-
ment of diabetes, body weight increases progressively, reaching 
a maximum at the time of diagnosis, and then it tends to decrease 
after diagnosis (6, 15-21). Considering this is an only cross-sec-
tional study to observe the association of obesity with degree of 
glucose intolerance, we could not confirm this result without 
further longitudinal follow-up study. However, this result sug-
gested different relationship between obesity and glucose intol-
erance in Korean population, compared to Western population.     
  It was well-known that obesity contributes to the development 
of T2DM (1-3) and weight control efforts are an important com-
ponent of the clinical management of diabetes (4, 5). The asso-
ciation between obesity and diabetes is indisputable (6, 15-21). 
A meta-analysis presented the overall relative risk of diabetes 
per unit of BMI and reported that diabetes risk increases by 1.19 
(95% CI:1.16-1.20) per unit of BMI and assumes a linear relation 
between BMI and the relative risk of diabetes (2). In our study, 
BMI and WC was associated with the presence of diabetes (FPG 
≥ 126 mg/dL or those with diabetes drug) independent of age, 
sex, current smoking, alcohol intake, systolic and diastolic blood 
pressure, LDL-cholesterol, triglyceride, and HDL-cholesterol, 
respectively (BMI, OR 1.095 [95% CI:1.047-1.145], P < 0.001 per 
unit of BMI; WC, OR 1.049 [95% CI 1.032-1.067], P < 0.001 per 
unit of WC) in logistic regression analysis. 
  A study involving Pima Indians reported a steady gain in 
weight before the diagnosis of diabetes (mean BMI increase of 
0.43-0.71 kg/m
2 per year), with weight declining following diag-
nosis (15). On the contrary that almost all Western studies con-
sistently showed that body weight reached a maximum at the 
time of diagnosis on type 2 diabetes (6, 15-18), we could not ob-
serve those findings in this study. Previously, we examined the 
medical records of 54,623 persons who attended a health pro-
motion center and observed that BMI increased gradually with 
an increase of FPG in the range of NFG and IFG. However, we 
could not find difference of obesity between IFG and diabetes 
(26). Oh et al. analyzed NFG and IFG population according to 
FPG level, as follows: NFG (< 100 mg/dL), stage 1 IFG (100-109 
mg/dL) and stage 2 IFG (110-125 mg/dL) in a pooled analysis 
of four community-based cohort studies in Korea, which was 
conducted by the Committee of the Korean Diabetes Associa-
Fig. 2. Age-adjusted body mass index according to fasting plasma glucose (FPG). Diabetes was defined as current medication of anti-diabetes or FPG ≥ 126 mg/dL. Data, 
mean ± SEM. 
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tion on the diagnosis and classification of diabetes mellitus (29). 
Although the main purpose of that study was whether stage 2 
IFG was poorer metabolic profile or not compared to IFG 1, BMI 
and WC in stage 2 IFG were significantly higher than those in 
stage 1 IFG, respectively (BMI, 24.6 ± 3.2 kg/m
2 vs 23.8 ± 3.3 kg/
m
2; WC, 86.8 ± 8.6 cm vs 83.9 ± 9.5 cm) on the contrary to our 
results. The reason of this discrepancy is not certain. One of pos-
sibility was the difference in characteristics of study population. 
Because major population of pooled analysis was originated 
from Korean rural area (Yonchon and Chongup), mean age of 
the pooled study was higher than that of our NFG and IFG par-
ticipants (pooled analysis, 52.1 ± 13.6 yr vs our study 48.0 ± 14.0 
yr), nevertheless our study included only participants older than 
25 yr. Another explanation could be difference of exclusion cri-
teria. On the contrary that the pooled study included whole pop-
ulation of four communities, we included only participants older 
than 25 yr for excluding the possibilities of type 1 DM and ex-
cluded participants with history of cancer, cerebrovascular dis-
ease, end stage renal disease, liver cirrhosis, and thyroid disease, 
which may cause its effect on weight. Among 5,531 persons with 
laboratory test and nutritional survey data, 4,479 persons aged 
26-99 yr were included as participants according to above men-
tioned inclusion criteria. 
  According to analysis of the 1999-2006 National Health and 
Nutrition Examination Survey in the United States (28), 80.3% 
of adult diabetics were considered overweight (BMI  ≥ 25 kg/m
2) 
and 49.1% of diabetics were considered obese (BMI  ≥ 30 kg/m
2). 
In 2001 KNHANES (29), the rate of BMI  ≥ 25 kg/m
2 was 48.4% 
and the rate of BMI  ≥ 30 kg/m
2 was 7.4% in diabetics. Lee et al. 
investigated 15,665 Korean diabetic subjects and found that 
67.6% had a BMI below 25 kg/m
2, and only 3.3% had a BMI over 
30 kg/m
2. Their study showed that the majority of Korean dia-
betics were non-obese and suggested the etiologic difference of 
type 2 diabetes in Korean subjects compared to Caucasians (30). 
The prevalence of type 2 diabetes among the second-generation 
Japanese-Americans is even 2-to 4-fold higher than that among 
western populations despite the fact that the second-generation 
Japanese-Americans are less obese than the Caucasians (31). 
The finding in our study that degree of obesity increased with 
an increase of FPG in range of FPG < 100 mg/dL, peaked in FPG 
of 100-109 mg/dL, and then plateaued in higher FPG range was 
comparable with above mentioned studies. These findings may 
imply that East Asians are more prone to develop diabetes for 
their degree of obesity. 
  Both insulin deficiency and insulin resistance have been known 
to be involved in the pathogenesis of type 2 diabetes. Weyer et 
al. showed that the inability of insulin secretion to compensate 
for the increase in insulin resistance distinguishes individuals 
who will develop diabetes from those who will retain NGT in 
Pima Indians (32). The relative importance of each factor may 
differ according to ethnicity. In previous study (12), we classi-
fied our 370 participants according to glucose intolerance into 
five groups (normal glucose, isolated IFG, isolated IGT, both 
IFG and IGT, and diabetes) after 75 g oral glucose tolerance test 
(OGTT). And we compared insulinogenic index (Δinsulin, 0 to 
30 min/Δplasma glucose, 0-30 min; an index of early-phase in-
sulin secretion during the OGTT) (33) and HOMA (R) (fasting 
serum insulin [μU/mL] × FPG [mM/L]/22.5; an index of insulin 
resistance) (34) among five groups. In that study, insulinogenic 
index significantly decreased in subjects with isolated IFG and 
isolated IGT compared to normal glucose but there was no dif-
ference in HOMA (R) among those with isolated IFG, isolated 
IGT, and normal glucose. This finding that insulinogenic index 
was the sole differentia among normal glucose, isolated IFG, and 
isolated IGT suggested the importance of early-phase insulin 
secretory defect in the pathogenesis of type 2 diabetes in Korea. 
The uniqueness of this study was that degree of obesity increased 
gradually with an increase of FPG, peaked in FPG of 100-109 mg/ 
dL, but no more increase of obesity in higher FPG range. There 
was no significant difference of obesity among FPG of 100-109 
mg/dL (stage 1 IFG), FPG of 110-125 mg/dL (stage 2 IFG), and 
diabetes. This finding implied that even in mild or stage 1 IFG, 
persons already reached their maximum obesity in the course 
of glucose tolerance deterioration in Korea. With this result, we 
can speculate that failure of insulin secretion to compensate obe-
sity-induced insulin resistance may be initiated in stage 1 IFG in 
Korean population. However, we should consider that this is not 
a longitudinal follow-up study for the same person’s weight but 
a cross-sectional observation of different person’s weight. An-
other study is necessary to confirm the suggestion of this study.  
  The study had several limitations. The first was that this was 
not a longitudinal follow-up for a participant’s weight change, 
but was rather a cross-sectional observation for the association 
of obesity with glucose tolerance state. The second was that we 
could not adjust the effect of treatment of diabetes including oral 
anti-diabetic drug and insulin for the association of obesity with 
glucose tolerance state. The strength of this study was that it was 
conducted based on nationally representative data of the civil-
ian, non-institutionalized Korean population. As far as we know, 
this is the first study about the association of obesity and glucose 
intolerance status in a representative population of Koreans. 
  In conclusion, we observed that BMI and WC were increased 
progressively according to glucose intolerance status before de-
velopment of diabetes in both males and females. The degree 
of obesity increases with increasing FPG in the NFG range, 
peaks in FPG of 100-109 mg/dL, and then plateaus in higher 
FPG range. Although this is only cross-sectional observation, 
this finding can be a clue for proper direction of further pro-
spective studies and proper strategies for diabetes prevention 
in Korea.Kang HM, et al.  •  Body Mass Index, Waist Circumference, and Glucose Tolerance Status
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